CDK5 and diabetic kidney disease: Additionally, the most recent study has demonstrated that miR-4645-3p exhibits a protective impact on podocyte injury and mitochondrial dysfunction in DKD by specifically targeting cyclin-dependent kinase 5 (Cdk5) [138].